StockData
PDS Biotechnology Corp logo

PDS Biotechnology Corp (PDSB) stock

PDSBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 0/30
$0.78−0.11 (-12.27%)

Close on Nov 18, 2026Market cap $43.89MP/E –Yield –

PDS Biotechnology operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

PDS Biotechnology's operating income for the twelve months ending Jun 30, 2026 was -$27.83M. For fiscal 2025 it was -$31.54M. The highest annual figure on record is -$3.65M in fiscal 2018.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$31.54M–
FY2024Dec 31, 2024-$36.32M–
FY2023Dec 31, 2023-$43.05M–
FY2022Dec 31, 2022-$41.67M–
FY2021Dec 31, 2021-$21.44M–
FY2020Dec 31, 2020-$14.90M–
FY2019Dec 31, 2019-$21.03M–
FY2018Dec 31, 2018-$3.65M–
FY2017Dec 31, 2017-$51.97M–
FY2016Dec 31, 2016-$39.51M–
FY2015Dec 31, 2015-$26.50M–
FY2014Dec 31, 2014-$13.19M–
FY2013Dec 31, 2013-$6.49M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$6.50M–
Q1 FY2026Mar 31, 2026-$6.52M–
Q4 FY2025Dec 31, 2025-$6.67M–
Q3 FY2025Sep 30, 2025-$8.14M–
Q2 FY2025Jun 30, 2025-$7.62M–
Q1 FY2025Mar 31, 2025-$9.11M–
Q4 FY2024Dec 31, 2024-$7.36M–
Q3 FY2024Sep 30, 2024-$10.18M–
Q2 FY2024Jun 30, 2024-$8.68M–
Q1 FY2024Mar 31, 2024-$10.10M–
Q4 FY2023Dec 31, 2023-$10.41M–
Q3 FY2023Sep 30, 2023-$10.52M–
Q2 FY2023Jun 30, 2023-$12.70M–
Q1 FY2023Mar 31, 2023-$9.42M–
Q4 FY2022Dec 31, 2022-$18.82M–
Q3 FY2022Sep 30, 2022-$7.28M–
Q2 FY2022Jun 30, 2022-$7.09M–
Q1 FY2022Mar 31, 2022-$8.48M–
Q4 FY2021Dec 31, 2021-$6.32M–
Q3 FY2021Sep 30, 2021-$6.96M–
Q2 FY2021Jun 30, 2021-$5.11M–
Q1 FY2021Mar 31, 2021-$3.05M–
Q4 FY2020Dec 31, 2020-$4.03M–
Q3 FY2020Sep 30, 2020-$3.91M–
Q2 FY2020Jun 30, 2020-$2.94M–
Q1 FY2020Mar 31, 2020-$4.03M–
Q4 FY2019Dec 31, 2019-$5.98M–
Q3 FY2019Sep 30, 2019-$5.85M–
Q2 FY2019Jun 30, 2019-$4.27M–
Q1 FY2019Mar 31, 2019-$4.94M–
Q4 FY2018Dec 31, 2018-$1.63M–
Q3 FY2018Sep 30, 2018-$710.27K–
Q2 FY2018Jun 30, 2018-$567.03K–
Q1 FY2018Mar 31, 2018-$736.94K–
Q4 FY2017Dec 31, 2017-$16.12M–
Q3 FY2017Sep 30, 2017-$10.90M–
Q2 FY2017Jun 30, 2017-$13.15M–
Q1 FY2017Mar 31, 2017-$11.79M–
Q4 FY2016Dec 31, 2016-$10.94M–
Q3 FY2016Sep 30, 2016-$10.28M–

More PDS Biotechnology figures

See a number that looks wrong?